Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
International Journal of Medical Sciences|March 27, 2020
Adipose Tissue-Derived Mesenchymal Stem Cells Suppress Growth of Huh7 Hepatocellular Carcinoma Cells via Interferon (IFN)-β-Mediated JAK/STAT1 Pathway <i>in vitro</i>Chun Sung Byun, Soonjae Hwang, Sung-Hun Woo, et al.
Cancer Medicine|August 12, 2020
Immunosuppressive role of CD11b<sup>+</sup> CD33<sup>+</sup> HLA-DR<sup>-</sup> myeloid-derived suppressor cells-like blast subpopulation in acute myeloid leukemiaShin Young Hyun, Eun Jung Na, Ji Eun Jang, et al.
Biochemical and Biophysical Research Communications|February 5, 2014
The role of growth factors in maintenance of stemness in bone marrow-derived mesenchymal stem cellsYoung Woo Eom, Ji-Eun Oh, Jong In Lee, et al.
Yonsei Medical Journal|October 27, 2011
Rapid isolation of adipose tissue-derived stem cells by the storage of lipoaspiratesYoung Woo Eom, Jong Eun Lee, Mal Sook Yang, et al.
Biochemical and Biophysical Research Communications|April 9, 2011
Effective myotube formation in human adipose tissue-derived stem cells expressing dystrophin and myosin heavy chain by cellular fusion with mouse C2C12 myoblastsYoung Woo Eom, Jong Eun Lee, Mal Sook Yang, et al.
Hepato-Gastroenterology|October 24, 2003
5-Fluorouracil, methotrexate, leucovorin, CDDP and epirubicin (FEPMTX): a wide-spectrum regimen of salvage chemotherapy for high-grade advanced gastric cancerKazuo Kinoshita, Yutaka Yonemura, Toshiharu Sawa, et al.
Growth Factors (Chur, Switzerland)|February 26, 2015
L-ascorbic acid 2-phosphate and fibroblast growth factor-2 treatment maintains differentiation potential in bone marrow-derived mesenchymal stem cells through expression of hepatocyte growth factorSung Hae Bae, Hoon Ryu, Ki-Jong Rhee, et al.
Cancers|November 10, 2020
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)Soohyeon Lee, Seock-Ah Im, Gun Min Kim, et al.
The Lancet. Oncology|November 1, 2019
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trialYeon Hee Park, Tae-Yong Kim, Gun Min Kim, et al.
Annals of Geriatric Medicine and Research|June 11, 2025
Standardized Measurement of Physical Performance and Muscle Strength for Sarcopenia: Expert-based Delphi ConsensusSeung-Kyu Lim, Jaewon Beom, Sang Yoon Lee, et al.
Pageof 10